Blog Voices from the Frontlines
The use of cannabis in response to the opioid crisis: A review of the literature - Americans for Safe Access
A staggering number of Americans are dying from overdoses attributed to prescription opioid medications (POMs). In response, states are creating policies related to POM harm reduction strategies, overdose prevention, and alternative therapies for pain management, such as cannabis (medical marijuana). However, little is known about how the use of cannabis for pain management may be associated with POM use.
Medical marijuana patients report reduction in use of prescription drugs - Americans for Safe Access
Some medical marijuana patients in Illinois say the drug has allowed them to reduce or eliminate their use of other prescription medication, a new study reports. The study by DePaul and Rush universities was small, with 30 participants, and involved only those who volunteered to respond to the topic, so researchers conceded the results might be biased in favor of marijuana. But it's believed to be the first peer-reviewed, published research of medical marijuana patients in Illinois.
In an attempt to reduce opioid use amid a nationwide abuse epidemic, insurance giant Cigna will no longer cover most OxyContin prescriptions in its group plans beginning January 1. "Our focus is on helping customers get the most value from their medications -- this means obtaining effective pain relief while also guarding against opioid misuse," Cigna Chief Pharmacy Officer Jon Maesner said in a statement Wednesday.
Former Pain Doc: 'If Opiates Didn’t Cause Tolerance, We Wouldn't Be Here' - Americans for Safe Access
Dr. Bobby Dey, a retired physician and pain management specialist, says that no one is at fault for America’s epidemic of opioid dependence and overdose—but that it had more to do with the nature of prescription painkillers themselves.
Drug, once rare, are now the in the U.S., surpassing peak annual deaths caused by motor vehicle accidents, guns and HIV infection. The data show that the situation is dire and getting worse. Until opioids are prescribed more cautiously and until effective opioid addiction treatment becomes easier to access, overdose deaths will likely remain at record high levels.
As seen with many medical conditions relating to treatment with marijuana, research into the benefits of the herb’s uses concerning rheumatism is still in its infancy. However, there have been a few rather interesting studies to date.
By Gillian Mohney for Healthline
Republican Senator Orrin Hatch of Utah has introduced a bill to relax medical marijuana research regulations.
“On the one hand, it’s a political victory. I think having a bill that even touches on the subject from Orrin Hatch is considered a win, but on the other hand, we’re of the mind the research is there, the research is done.[Medical marijuana] programs have been around for 20 years. A research bill was more appropriate in the late 1990s and early 2000s.” - David Mangone, JD
Trump: Declare a National Emergency so states can use cannabis to fight opioid overdoses. - Americans for Safe Access
Opioids claim the lives of 91 individuals every day. With nearly 60,000 overdose deaths in 2016, 60% of which were related to prescription opioids, it is clear that there is a major public health crisis in our country. That is why we are launching our End Pain Not Lives campaign.
Dr. Nagel, who wrote an excellent book on chronic pain called Needless Suffering; How Society Fails Those With Chronic Pain, has been speaking on the issue since his book came out. I shared with him what feels like an intensifying anger and parallel hopelessness that has set in among some of our readers and presumably among many more chronic pain patients.
The Effects of Medical Marijuana Dispensaries on Adverse Opioid Outcomes - Americans for Safe Access
This paper uses a unique marijuana dispensary dataset to exploit within- and across-state variation in dispensary openings to estimate the effect increased access to marijuana has on narcotic-related admissions to treatment facilities and drug-induced mortalities. I find that core-based statistical areas (CBSAs) with dispensary openings experience a 20 percentage point relative decrease in painkiller treatment admissions over the first two years of dispensary operations.